Form 4: Hanover Insurance Group CEO John Roche Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Hanover Insurance Group's CEO, John Roche, exercised stock options and sold shares according to a pre-established Rule 10b5-1 trading plan, while also receiving restricted stock units related to dividend equivalent rights.
Summary
- On March 28, 2025, John Roche, the President and CEO of Hanover Insurance Group, exercised options to purchase 400 shares of common stock at a price of $77.91 and sold the same amount at $175.03.
- On March 31, 2025, Roche exercised options to purchase 301 shares of common stock at a price of $77.91 and sold the same amount at $175.
- These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on November 5, 2024.
- Roche also acquired 135.857 restricted stock units (RSUs) related to dividend equivalent rights under the company's 2022 Long-Term Incentive Plan, which vest on the third anniversary of the original RSU grant date.
- Following these transactions, Roche directly owns 124,413.708 shares of Hanover Insurance Group common stock, excluding 14,454 shares held by his spouse.
- He also holds options to purchase 8,906 shares of common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The CEO is exercising options and selling shares, which could be seen as a positive sign of confidence in the company, but it's also part of a pre-planned strategy.
Positives
- The use of a pre-established Rule 10b5-1 trading plan suggests that the transactions were planned in advance and not based on any inside information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan is a common practice to avoid accusations of insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 2024-11-05 | Date of adoption of Rule 10b5-1 Trading Plan |
| 2025-03-28 | Exercise of options and sale of 400 shares |
| 2025-03-28 | Grant of restricted stock units |
| 2025-03-31 | Exercise of options and sale of 301 shares |
| 2026-02-23 | Expiration date of options |
Keywords
Form 4, Hanover Insurance Group, John Roche, Stock Options, Rule 10b5-1, Restricted Stock Units, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.